Table 3 |
||||
|
IC50 of MCF-7 cells after 24-, 48-, 72-h incubation with docetaxel formulated in the Taxotere®, 5% DMAB-modified PLGA nanoparticles (ANP), unmodified PLGA-TPGS nanoparticles (BNP) and 5% DMAB-modified PLGA-TPGS nanoparticles (CNP) |
||||
|
Incubation time (h) |
IC50(μg/ml) |
|||
|
|
||||
|
ANP |
BNP |
CNP |
Taxotere® |
|
|
|
||||
|
24 |
1.144 |
1.300 |
0.121 |
2.610 |
|
48 |
0.926 |
0.590 |
0.088 |
1.640 |
|
72 |
0.272 |
0.204 |
0.054 |
0.911 |
|
|
||||
|
Chen et al. Nanoscale Res Lett 2011 6:4 doi:10.1007/s11671-010-9741-8 |
||||
